SeraCare announces industry’s first CNV-specific reference material for gene amplifications in breast, lung, and brain cancer.
NHGRI launches a new strategic plan to identify areas in genomics that will expand the field into new frontiers and enable novel applications to human health and disease.
The GA4GH roadmap outlines the first set of standards and frameworks to be launched under GA4GH Connect—a new phase of the organization focused on aligning with the needs of the real-world genomic data sharing community.
SOPHiA GENETICS has unveiled the world’s first capture-based myeloid clinical solution to receive the CE-IVD mark. The standardized molecular diagnostic application represents a breakthrough in diagnostics for hematological diseases.
In the 18 months that the Wolfson Childhood Research Centre has been open, researchers have secured a further £5 million in grants to continue world-class childhood cancer research.
The Human Genome Project has been awarded the 2017 Prince Mahidol Award for ground-breaking advances in the field of medicine.
Illumina Ventures- and Merck-backed DNA Script have gotten one step closer to its vision of higher speed, higher efficiency, harsh-chemical free DNA synthesis.
Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, has today announced the expansion of its international commercial operations.
SOPHiA GENETICS announced at the Precision Medicine World Conference (PMWC) in Silicon Valley that its artificial intelligence, SOPHiA, has gained radiomics capabilities.
This year at SLAS 2018, the Formulatrix will be unveiling a concept for a novel automation platform that offers so many benefits to researchers preparing samples that it is surprising others have not beat them to the punch.
Beckman Coulter Life Sciences have launched a family of FormaPure reagent kits for extracting nucleic acid from often challenging formalin-fixed, paraffin-embedded (FFPE) tissues.
Sick and tired of dealing with generic drug shortages and unpredictable price increases, five large U.S. health systems are taking an unusual step: they’re forming their own nonprofit generic drugmaker.
In a scientific first, researchers turned skin cells from mice into stem cells by activating a specific gene in the cells using CRISPR technology.
Dawn Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth.
The new, next-generation sequencing (NGS) system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab.